On this page you’ll find the latest updates on FARF-funded research and activities, updated on an ongoing basis.
FA is associated with bone marrow failure, cancer predisposition, and congenital abnormalities. What do we know about central nervous system abnormalities?
Read updates about FA cancer research shared at the 2019 FARF Scientific Symposium
An update on three FA clinical trials presented at the 2019 FARF Scientific Symposium
Aldehydes can cause DNA damage to hematopoietic stem cells, leading to bone marrow failure and cancer. Where are we with research into aldehydes in FA? Read this update from the 2019 Symposium.
At the 2019 FARF Scientific Symposium in Chicago, Dr. Grant Rowe became the fourth recipient of the David B. Frohnmayer Early Investigator Award.
In September 2019, more than 200 researchers and clinicians in the FA community gathered in Chicago to share updates in research and care. Here are some of the highlights.